ArticlePostepy dermatologii i alergologii2026
The use of cosmetic and medical products for skin protection in athletes during training and competitions.
Article in Postepy dermatologii i alergologii, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Athletes' skin is exposed to multiple adverse factors during training and competitions, including ultraviolet radiation, mechanical friction, sweating, and contact with water or equipment. Effective skin protection is essential for preserving health and performance. Aim: To investigate the patterns of cosmetic and medical product use for skin protection among athletes of different sports disciplines and identify key factors influencing product choice and dermatological outcomes. Material and methods: A cross-sectional descriptive study was conducted from May 2023 to May 2025 in Kyiv, Ukraine, including 386 athletes (212 women, 174 men) from outdoor, aquatic, and contact/strength sports. Data were collected using a structured online questionnaire covering socio-demographics, frequency and regularity of product use, dermatological problems, and sources of information. Descriptive statistics and chi-square tests (χ Results: Sunscreens were the most commonly used products (87.3%), followed by moisturisers (81.1%), antiseptics (74.9%), barrier agents (58.3%), and specialised products (45.1%). Gender analysis revealed significant differences: 59% of women used moisturisers regularly versus 25.9% of men, and 51.9% of women systematically used sunscreens versus 34.5% of men, indicating a proactive-preventive approach in women and a reactive pattern in men. Dermatological issues were prevalent: friction injuries and abrasions (85%), skin dryness (78%), sunburns (64%), acne and folliculitis (50%), and fungal infections (30%). Specific patterns emerged by sports: aquatic athletes experienced high skin dryness (92.9%), outdoor athletes high sunburn rates (83.9%), and contact/strength athletes high friction injuries (99.2%). Coaches (76.9%) and peers (71%) were the primary influencers on product choice, while medical specialists influenced 62.9% of respondents. Despite high sunscreen use, 64% still reported burns, highlighting gaps in the application technique or SPF adequacy. Conclusions: Athletes demonstrate sport- and gender-specific skin care behaviours, with a high prevalence of dermatological problems despite widespread use of protective products. Different dermatological protocols and educational programs for athletes, coaches, and medical staff are recommended to optimise skin protection, prevent complications, and enhance early detection of dermatological conditions. The study underscores the need for greater involvement of dermatologists in sports medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.